<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy</title>
  <description>Editor-in-Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author David Goldenberg, MD, to discuss&amp;amp;nbsp;role of estrogen in developing thyroid malignancy as outlined in the paper “Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy” which published in the April 2025 issue of&amp;amp;nbsp;Otolaryngology–Head and Neck Surgery. They&amp;amp;nbsp;talk about the risk of thyroid cancer for biological males taking estrogen compared to men not undergoing hormone therapy and women. &amp;amp;nbsp;  Click here to read the full article. </description>
  <author_name>OTO Journal</author_name>
  <author_url>https://sites.libsyn.com/54812</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/36365190/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/36365190</thumbnail_url>
</oembed>
